Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis, Nicolas
Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. [electronic resource] - Current cancer drug targets Dec 2010 - 922-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-5576
10.2174/156800910793357952 doi
CD55 Antigens--chemistry
CD59 Antigens--chemistry
Complement Activation--genetics
Flow Cytometry
Humans
Membrane Cofactor Protein--antagonists & inhibitors
Neoplasms--genetics
RNA, Messenger--genetics
RNA, Neoplasm--genetics
RNA, Small Interfering--genetics
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. [electronic resource] - Current cancer drug targets Dec 2010 - 922-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-5576
10.2174/156800910793357952 doi
CD55 Antigens--chemistry
CD59 Antigens--chemistry
Complement Activation--genetics
Flow Cytometry
Humans
Membrane Cofactor Protein--antagonists & inhibitors
Neoplasms--genetics
RNA, Messenger--genetics
RNA, Neoplasm--genetics
RNA, Small Interfering--genetics
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured